Institute of Reproductive and Stem Cell Engineering, NHC Key Laboratory of Human Stem Cell and Reproductive Engineering, School of Basic Medical Sciences, Central South University, Changsha, China.
Clinical Research Center for Reproduction and Genetics in Hunan Province, Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha, China.
J Assist Reprod Genet. 2024 Jun;41(6):1485-1498. doi: 10.1007/s10815-024-03106-9. Epub 2024 Apr 3.
This study aimed to identify the genetic causes of male infertility and primary ciliary dyskinesia (PCD)/PCD-like phenotypes in three unrelated Han Chinese families.
We conducted whole-exome sequencing of three patients with male infertility and PCD/PCD-like phenotypes from three unrelated Chinese families. Ultrastructural and immunostaining analyses of patient spermatozoa and respiratory cilia and in vitro analyses were performed to analyze the effects of SPEF2 variants. Intracytoplasmic sperm injection (ICSI) was administered to three affected patients.
We identified four novel SPEF2 variants, including one novel homozygous splicing site variant [NC_000005.10(NM_024867.4): c.4447 + 1G > A] of the SPEF2 gene in family 1, novel compound heterozygous nonsense variants [NC_000005.10(NM_024867.4): c.1339C > T (p.R447*) and NC_000005.10(NM_024867.4): c.1645G > T (p.E549*)] in family 2, and one novel homozygous missense variant [NC_000005.10(NM_024867.4): c.2524G > A (p.D842N)] in family 3. All the patients presented with male infertility and PCD/likely PCD. All variants were present at very low levels in public databases, predicted to be deleterious in silico prediction tools, and were further confirmed deleterious by in vitro analyses. Ultrastructural analyses of the spermatozoa of the patients revealed the absence of the central pair complex in the sperm flagella. Immunostaining of the spermatozoa and respiratory cilia of the patients validated the pathogenicity of the SPEF2 variants. All patients carrying SPEF2 variants underwent one ICSI cycle and delivered healthy infants.
Our study reported four novel pathogenic variants of SPEF2 in three male patients with infertility and PCD/PCD-like phenotypes, which not only extend the spectrum of SPEF2 mutations but also provide information for genetic counseling and treatment of such conditions.
本研究旨在鉴定三个无关汉族男性不育和原发性纤毛运动障碍(PCD)/PCD 样表型患者的遗传病因。
我们对三个来自三个无关汉族家庭的男性不育和 PCD/PCD 样表型患者进行了全外显子组测序。对患者精子和呼吸道纤毛进行超微结构和免疫染色分析,并进行体外分析以研究 SPEF2 变异的影响。对三名受影响的患者进行了胞浆内单精子注射(ICSI)。
我们鉴定出四个新的 SPEF2 变异,包括家族 1 中 SPEF2 基因的一个新的纯合剪接位点变异[NC_000005.10(NM_024867.4):c.4447+1G>A],家族 2 中新型复合杂合无义变异[NC_000005.10(NM_024867.4):c.1339C>T(p.R447*)和 NC_000005.10(NM_024867.4):c.1645G>T(p.E549*)],以及家族 3 中一个新的纯合错义变异[NC_000005.10(NM_024867.4):c.2524G>A(p.D842N)]。所有患者均表现为男性不育和 PCD/可能的 PCD。所有变异在公共数据库中的存在水平均非常低,在计算机预测工具中预测为有害,并且通过体外分析进一步证实了其有害性。患者精子的超微结构分析显示精子鞭毛中不存在中央对复合物。患者精子和呼吸道纤毛的免疫染色验证了 SPEF2 变异的致病性。所有携带 SPEF2 变异的患者均接受了一次 ICSI 周期,并分娩了健康婴儿。
本研究报道了三个男性不育和 PCD/PCD 样表型患者中 SPEF2 的四个新的致病性变异,不仅扩展了 SPEF2 突变谱,而且为此类疾病的遗传咨询和治疗提供了信息。